62760-10-5

Basic information

• Product Name: 2-CHLOROETHYL-2-ACETYL-2-((3-NITROPHENYL)METHYLENE)ACETATE
• Synonyms: 2-CHLOROETHYL-2-ACETYL-2-((3-NITROPHENYL)METHYLENE)ACETATE;2-CHOLROETHYL-2-ACETYL-2-((3-NITROPHENYL)METHYLENE)ACETATE;2-Chloroethyl-2-((3-nitrophenyl)methylene)-3-oxobutanoate
• CAS NO: 62760-10-5
• Molecular Formula: C₁₃H₁₂ClNO₅
• Molecular Weight: 297.69108
• Mol File: 62760-10-5.mol
• Article Data: 3

Chemical Properties

• Melting Point: 68-76 °C
• Boiling Point: 448.7±45.0 °C(Predicted)
• Appearance: /
• Density: 1.352±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 2-CHLOROETHYL-2-ACETYL-2-((3-NITROPHENYL)METHYLENE)ACETATE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-CHLOROETHYL-2-ACETYL-2-((3-NITROPHENYL)METHYLENE)ACETATE(62760-10-5)
• EPA Substance Registry System: 2-CHLOROETHYL-2-ACETYL-2-((3-NITROPHENYL)METHYLENE)ACETATE(62760-10-5)

Safety Data

• Hazardous Substances Data: 62760-10-5(Hazardous Substances Data)

Upstream product

• 54527-68-3 2-chloroethyl acetoacetate 
• 99-61-6 3-nitro-benzaldehyde 

Downstream Products

• 75091-01-9 2-Cyano-6-methyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 5-{2-[(3,4-dichloro-benzyl)-methyl-amino]-ethyl} ester 3-ethyl ester 
• 74655-11-1 2-Cyano-6-methyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 5-{2-[(4-chloro-benzyl)-methyl-amino]-ethyl} ester 3-ethyl ester 
• 62760-80-9 2-(N-methyl-N-benzylamino)ethyl 2-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-hydroxymethyl-1,4-dihydropyridine-3-carboxylate 
• 74654-94-7 2-Diethoxymethyl-6-methyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 5-{2-[(3,4-dichloro-benzyl)-methyl-amino]-ethyl} ester 3-ethyl ester 
• 74654-93-6 2-Diethoxymethyl-6-methyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 5-{2-[(4-chloro-benzyl)-methyl-amino]-ethyl} ester 3-ethyl ester 
• 74655-03-1 2-Formyl-6-methyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 5-{2-[(3,4-dichloro-benzyl)-methyl-amino]-ethyl} ester 3-ethyl ester 
• 74655-02-0 2-Formyl-6-methyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 5-{2-[(4-chloro-benzyl)-methyl-amino]-ethyl} ester 3-ethyl ester 
• 74655-19-9 2-Cyano-6-methyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 5-(2-acetoxy-ethyl) ester 3-ethyl ester 
• 75530-90-4 2-hydroxyethyl 2-cyano-3-ethoxycarbonyl-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-5-carboxylate 
• 75090-92-5 2-Formyl-6-methyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-ethyl ester 5-(2-hydroxy-ethyl) ester 
• 62760-16-1 2-hydroxyethyl 2-diethoxymethyl-3-ethoxycarbonyl-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-5-carboxylate 
• 62760-14-9 2-(N-benzyl-N-methyl)aminoethyl 2-diethoxymethyl-3-ethoxycarbonyl-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-5-carboxylate 
• 62760-53-6 2-(N-benzyl-N-methylamino)ethyl 2-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-cyano-1,4-dihydropyridine-3-carboxylate 
• 62760-35-4 2-(N-methyl-N-benzylamino)-ethyl 2-methyl-4-(3-nitrophenyl)-5-ethoxycarbonyl-6-formyl-1,4-dihydropyridine-3-carboxylate 

Relevant articles and documents

Asymmetric N-(3,3-diphenylpropyl)aminoalkyl esters of 4-aryl-2,6- dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acids with antihypertensive activity

A series of asymmetric 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates characterized by the presence of a 3,3-diphenylpropylamino moiety in one of the ester groups were synthesized. They exhibited remarkable antihypertensive activity in spontaneously hypertensive rats as well as affinity for the 1,4- dihydropyridines binding site labelled by 3H-nitrendipine in the calcium channel. Introduction of this bulky and lipophilic amine confers to the whole series an elevated level of antihypertensive activity and a long duration of action, a structure-dependent modulation of the activity being found only in the subset characterized by the presence of a branched propylene bridge between the ester and the amino groups. The presence of the amino group is essential for oral activity. Out of this series, compound 9u (Rec 15/2375- lercanidipine) was selected for clinical development and obtained marketing authorization as an antihypertensive in several countries.

Carbostyril Derivative

Carbostyril derivative or a pharmaceutically acceptable acid addition salt thereof, having excellent platelate aggregation inhibitory effect, calcium antagonism, hypotensive effect and phosphodiesterase inhibitory effect are useful as prophylactic or treating agents for thrombosis, circulation improving agents for coronary blood flow such as coronary vasodilators, hypotensive agents and phosphodiesterase inhibitors. Furthermore, the carbostyril derivatives are weak in heart rate increasing activity and also in cardiac muscle contraction increasing activity, and the carbostyril derivatives are useful agents for curing and treating heart diseases such as cardiac angina and myocardial infarction caused by hypercoagulability of the platelets. Processes are disclosed for preparation of the carbostyril derivatives.